T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.73 CNY -2.24% Market Closed
Market Cap: 17B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd

Wall Street analysts forecast Tonghua Dongbao Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 12.39 CNY with a low forecast of 9.09 CNY and a high forecast of 14.78 CNY.

Lowest
Price Target
9.09 CNY
4% Upside
Average
Price Target
12.39 CNY
42% Upside
Highest
Price Target
14.78 CNY
69% Upside
Tonghua Dongbao Pharmaceutical Co Ltd Competitors:
Price Targets
RHONEMA
Rhone Ma Holdings Bhd
1% Upside
603998
Hunan Fangsheng Pharmaceutical Co Ltd
30% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
29% Upside
DPHARMA
Duopharma Biotech Bhd
21% Upside
ACB
Aurora Cannabis Inc
57% Upside
SAN
Sanofi SA
22% Upside
4151
Kyowa Kirin Co Ltd
34% Upside
AMRX
Amneal Intermediate Inc
17% Upside

Revenue
Forecast

Revenue Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 3%.

8%
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 7%.

11%
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is -8%.

11%
Past Growth
-8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tonghua Dongbao Pharmaceutical Co Ltd's stock price target?
Price Target
12.39 CNY

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 12.39 CNY with a low forecast of 9.09 CNY and a high forecast of 14.78 CNY.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 3%.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 7%.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is -8%.

Back to Top